bioRxiv · 10.1101/2023.07.22.550133
Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension
Abstract
Persistent liver injury triggers a fibrogenic program that causes pathologic remodelling of the hepatic microenvironment (i.e., liver fibrosis) and portal hypertension. The dynamics of gene regulation during liver disease progression and regression remain understudied. Here, we generated hepatic transcriptome profiles in two well-established liver disease models at peak fibrosis and during spontaneous regression after the removal of the inducing agents. We linked the dynamics of key liver disease readouts, such as portal pressure, collagen proportionate area, and transaminase serum levels, to most differentially expressed genes, enabling the identification of transcriptomic signatures of progressive vs. regressive liver fibrosis and portal hypertension. These candidate biomarkers (e.g., Scube1, Tcf4, Src, Hmga1, Trem2, Mafk, Mmp7) were also validated in RNA-seq datasets of patients with cirrhosis and portal hypertension. Finally, deconvolution analysis identified major cell types and suggested an association of macrophage and portal hepatocyte signatures with portal hypertension and fibrosis area in both models.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Petrenko, O., Koenigshofer, P., Brusilovskaya, K., Hofer, B. S., Bareiner, K., Simbrunner, B., Trauner, M., Kauschke, S. G., Pfisterer, L., Simon, E., Rendeiro, A., de Rooij, L., Schwabl, P., Reiberger, T.. 2023-07-25. Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension. https://doi.org/10.1101/2023.07.22.550133
Cite the original work for its findings. Save a collection to share your selection of sources.